Research Beam

Pain Management Drugs Market Is Expected to Register a CAGR of 4% from 2017 to 2023


Portland, OR -- (SBWIRE) -- 06/19/2018 -- Research Beam recently published a report titled, "Pain Management Drugs Market Report". The pain management drugs market is expected to reach a CAGR of 4% in the period from 2017 to 2023. The report offers an in-depth analysis of the major segments, Porter's Five Forces, drivers & restraints, and key market players. These factors help market players, investors, new entrants, and stakeholders to determine the opportunities and challenges in the market. The report analyzes several factors that are responsible for the ups and downs in the market such as drivers, restraint, opportunities, and challenges.

For More Info, Get Sample:

The report provides detailed summary of the market along with an overview of the pain management drugs market, definition, and scope. Key findings are stressed based on top investment pockets and positioning of top players. Research methodology employed by analysts is mentioned in the report.

The report includes several factors that affect the market growth such as drivers and restraints. According to the analysis, the recent surge in generic population is the prime factor that drives the growth of the pain management drugs market as aged people are more susceptible to joint pain and other chronic diseases. Moreover, the rise in prevalence of chronic diseases including cancer, diabetic neuropathy, and osteoarthritis increases the pain management drugs market growth. However, there are numerous factors that impede the market growth. The increased number of surgical procedures and rise in healthcare expenses hinders the pain management drugs market growth. In addition, drug exploitation, availability of substitutes such as pain relief devices, and patent expiration of surgical procedure impedes the growth of the pain management drugs market.

Enquire About Report:

The pain management drugs market report is segmented into drug class, indication, and region. Based on drug class, the market is divided into nonsteroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, antimigraine agents, opioids, anesthetics, antidepressants, and nonnarcotic analgesics. Opioids are further segmented into tramadol, oxycodone, hydrocodone, and others (fentanyl, meperidine, methadone, morphine, codeine). By indication, the market is bifurcated into arthritic pain, cancer pain, postoperative pain, fibromyalgia, neuropathic pain, chronic back pain, and migraine. Based on region, the pain management drugs market report is divides into North America, Asia-Pacific, Europe, and LAMEA.

The pain management drugs market report analyzes the current leading industries in the market to understand the competitive scenario. The key market players that are profiled in the report are Novartis AG, Abbott Laboratories, Purdue Pharma L.P., F. Hoffmann La Roche Ltd., Johnson & Johnson, Eli Lilly & Company, Endo Health Solutions, Inc., Pfizer, Inc., Merck & Co. Inc., and GlaxoSmithKline Plc.

Get 15% Discount:

About Research Beam
We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can help you with your growth opportunities. Research Beam will always make sure to bring most ethical and high-quality reports. We value your relationship with us and look forward for a long-term relation.

Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452